Welcome to the School of Pharmacy

Watch our Pharmacy video.

If you want a rewarding career supporting the health of people and communities through better medicines and usage, then study Pharmacy with us at the University of Auckland.

Scientific advances mean that in modern healthcare people benefit from having a range of experts involved in their health care needs.

Increasingly teams of healthcare professionals such as nurses, doctors and pharmacists are working together and using their individual expertise to maximise people’s health.  Pharmacists are the medicines experts. They are concerned with ensuring that people receive the most suitable medicines and receive the maximum health benefit from them.

To achieve this pharmacists spend much of their time talking to patients and their whānau, carers and a range of health care professionals about medicines. Pharmacists work in a variety of roles and their direct role in patient care is expanding. This allows pharmacists to directly help more people get the most from their medicines.

Our Bachelor of Pharmacy degree has been changed substantially in recent years to better equip graduates with the skills and knowledge to fulfil the vital role of a pharmacist in the rapidly changing world of healthcare.


About Our School

The University of Auckland’s School of Pharmacy is at the forefront of pharmacy education internationally*; we firmly believe our graduates measure up against the world’s best.

We are dedicated to not only producing high quality, research-literate graduates but to also improving the health of all New Zealanders by focusing on the best use of medicines in our society. We believe that theory along with practical education helps better prepare our students for their careers as pharmacists in a variety of settings.

Since our establishment in 2000, we have set up world class postgraduate programmes* offering Research Masters and PhD students the opportunity to work with, and learn from, experts in their field. Our academic staff have also been successful in bringing in research funding from national and international sources and have significant research collaborations throughout New Zealand and overseas.

The University of Auckland and its reputation for excellence, education and research, opens a world of possibilities for your Pharmacy career. 

* Top university in New Zealand for Medicine, Pharmacy and Pharmacology; in the top 100 worldwide (2015–16 QS World University Rankings)

  • Dr Daniel Exeter
    New tool to help distribute resources by identifying areas of need
    07 August 2017
    Research by the University of Auckland has created a new way of measuring social deprivation in New Zealand that could assist agencies to distribute resources better.
  • cancer_80px
    Potential break against killer disease
    01 August 2017
    A new cancer treatment developed by a team of University of Auckland scientists is being hailed internationally as a potential breakthrough in the fight against the disease.
  • Chris Bullen_Prof
    Rise in e-cigarettes linked to rise in smokers quitting, say researchers
    31 July 2017
    New research studying United States smokers has shown the recent rise in e-cigarette use in that country is getting more smokers quitting, according to Professor Chris Bullen of the University of Auckland.
  • Professor Boyd Swinburn Faculty of Medical and Health Sciences
    Experts call for action to fill gaps on healthy food policies
    24 July 2017
    New Zealand needs major improvements in food policies if it is going to seriously tackle the country’s obesity epidemic, according to findings in the University of Auckland’s second Healthy Food Environment Policy Index (Food-EPI) published today.
  • cbr-thumbnail-MS
    Research update on Multiple Sclerosis
    17 July 2017
    Dr Scott Graham, expert in neuroinflammation, and co-investigators Dr Jennifer Pereira; ADHB’s leading MS neurologist, and Dr Simon O’Carroll; Director of the Spinal Cord Injury Research Facility (SCIRF), are investigating an unknown soluble substance that appears to have an effect on the permeability of the brain in patients with MS.